Thyroid Disorders Associated with Cancer Immunotherapy

1,343
Total downloads
11k
Total views and downloads

Articles

ORIGINAL RESEARCH

Published on 10 Nov 2025

Pre-existing subclinical hypothyroidism and low free thyroxine in patients undergoing immune checkpoint inhibitor therapies is a risk factor for overt hypothyroidism

Yu Bai
Yue Yin
Hong Liu

doi 10.3389/fendo.2025.1690196

1,065 views

ORIGINAL RESEARCH

Published on 27 Oct 2025

Mapping the genetic–transcriptional landscape of thyroid irAEs in sintilimab therapy: toward biomarker-guided immunotoxicity prediction

Wei Chen
Mingyu Zhang
Taifeng Li
Bing Shang
Haishuai Su
Yafei Shi
Yutao Liu
Feng Yu
Guohui Li

doi 10.3389/fimmu.2025.1671594

1,788 views

ORIGINAL RESEARCH

Published on 12 Jun 2025

T3 and T4 autoantibodies: emerging biomarkers for evaluating thyroid disorders

Jiameng Liu
Chaoming Mao
Xueqian Mao
Xi Wang
Tingting Zheng
Liyang Dong
Yufei Mao

doi 10.3389/fendo.2025.1537222

2,554 views
1 citation

REVIEW

Published on 04 Jun 2025

Immune checkpoint inhibitor-induced thyroiditis and its potential mechanisms

Xueqian Mao
Chaoming Mao
Jiameng Liu
Xi Wang
Yufei Mao

doi 10.3389/fendo.2025.1584675

3,813 views
4 citations

Share on

Frontiers in Endocrinology

Frontiers in Endocrinology

Thyroid Endocrinology
Cancer Endocrinology

Impact

11kTopic views
8,727Article views
1,343Article downloads